{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:24:48Z","timestamp":1790267088301,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:15:49Z","timestamp":1692263749000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Autoimmune Hepatitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Mitchell L.","family":"Shiffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2023.06.002_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM195102152440702","article-title":"Extreme hyperglobulinema in subacute hepatic necrosis","volume":"244","author":"Zimmerman","year":"1951","journal-title":"N\u00a0Engl J Med"},{"issue":"6957","key":"10.1016\/j.cld.2023.06.002_bib2","first-page":"1323","article-title":"Lupoid hepatitis","volume":"271","author":"Cowling","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2023.06.002_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","article-title":"Autoimmune hepatitis","volume":"124","author":"Mackay","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cld.2023.06.002_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/hepr.13776","article-title":"Clinical practice guidelines for autoimmune hepatitis","volume":"52","author":"Ohira","year":"2022","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2023.06.002_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","article-title":"Prevalence and epidemiology of autoimmune hepatitis","volume":"6","author":"Boberg","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2023.06.002_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cld.2023.06.002_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/08830185.2014.921162","article-title":"Pathogen infection as a possible cause for autoimmune hepatitis","volume":"33","author":"Christen","year":"2014","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.cld.2023.06.002_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-015-8493-8","article-title":"Environmental basis of autoimmunity","volume":"50","author":"Floreani","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cld.2023.06.002_bib11","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib13","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1440-1746.2003.03165.x","article-title":"Epidemiology of autoimmune liver disease","volume":"18","author":"Feld","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib15","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib16","first-page":"611","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.cld.2023.06.002_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in The Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","author":"Czaja","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2023.06.002_bib19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/hep.32653","article-title":"Sociodemographic and geographic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis","volume":"77","author":"Bittterman","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.42.5.599","article-title":"The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis","volume":"42","author":"McFarlane","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.06.002_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib24","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner","year":"2015","journal-title":"Int J Celiac Dis"},{"key":"10.1016\/j.cld.2023.06.002_bib25","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00296-018-4091-4","article-title":"Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada","volume":"38","author":"Fatoye","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cld.2023.06.002_bib26","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/art.42330","article-title":"Increasing prevalence of antinuclear antibodies in the United States","volume":"74","author":"Dinse","year":"2022","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cld.2023.06.002_bib27","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/eji.1830221134","article-title":"Altered major histocompatibility complex-restricted antigen recognition by T\u00a0cells from elderly humans","volume":"22","author":"Schwab","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cld.2023.06.002_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0090-1229(88)90022-0","article-title":"Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population","volume":"48","author":"De Paoli","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cld.2023.06.002_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(68)92893-6","article-title":"Reciprocal change with age in antibody to extrinsic and intrinsic antigens","volume":"2","author":"Rowley","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2023.06.002_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MCG.0b013e318228b781","article-title":"The impact of race\/ethnicity on the clinical epidemiology of autoimmune hepatitis","volume":"46","author":"Wong","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib31","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis","volume":"46","author":"Verma","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib32","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","article-title":"Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis","volume":"174","author":"Czaja","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cld.2023.06.002_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigen DR4 and A1\u2013B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib36","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.06.002_bib37","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.1840120609","article-title":"Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients","volume":"12","author":"Seki","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib38","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","article-title":"HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients","volume":"103","author":"Seki","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.06.002_bib39","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/0270-9139(94)90230-5","article-title":"Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis","volume":"19","author":"Marcos","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib40","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type 1 autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib41","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/jhep.2001.24562","article-title":"Protracted, but not acute, hepatitis Avirus infection is strongly associated with HLA-DRB1\u22171301, a marker for pediatric autoimmune hepatitis","volume":"33","author":"Fainboim","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib42","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib43","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","article-title":"Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals","volume":"346","author":"Vento","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2023.06.002_bib44","doi-asserted-by":"crossref","first-page":"e85330","DOI":"10.1371\/journal.pone.0085330","article-title":"Increased HEV seroprevalence in patients with autoimmune hepatitis","volume":"9","author":"Pischke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2023.06.002_bib45","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3748\/wjg.v29.i12.1838","article-title":"Autoimmune liver diseases and SARS-CoV-2","volume":"29","author":"Sgamato","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/MEG.0000000000000424","article-title":"Autoimmune liver disease and concomitant extrahepatic autoimmune disease","volume":"27","author":"Muratori","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0b013e31802dbdfc","article-title":"Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background","volume":"42","author":"Bittencourt","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib48","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.06.002_bib49","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.2196\/ijmr.9625","article-title":"Extrahepatic autoimmune diseases are prevalent in autoimmune hepatitis patients and their first-degree relatives: survey study","volume":"7","author":"Fogel","year":"2018","journal-title":"Interact J Med Res"},{"key":"10.1016\/j.cld.2023.06.002_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cld.2018.12.007","article-title":"Rheumatologic diseases and the liver","volume":"23","author":"Gebreselassie","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2023.06.002_bib51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/liv.13236","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2023.06.002_bib53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cld.2018.12.001","article-title":"The liver and celiac disease","volume":"23","author":"Rubio-Taia","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2023.06.002_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rdc.2017.09.008","article-title":"Rheumatic manifestations in autoimmune liver disease","volume":"44","author":"Selmi","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.cld.2023.06.002_bib56","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2169\/internalmedicine.52.9458","article-title":"Liver dysfunction in patients with systemic lupus erythematosus","volume":"52","author":"Takahashi","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.cld.2023.06.002_bib57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-021-08888-9","article-title":"Autoimmune hepatitis: serum autoantibodies in clinical practice","volume":"63","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cld.2023.06.002_bib58","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib59","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib60","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cld.2023.06.002_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0025-6196(12)62106-5","article-title":"Clinical features and prognostic indications of severe corticosteroid treated cryptogenic chronic active hepatitis","volume":"65","author":"Czaja","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cld.2023.06.002_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.1990.tb01624.x","article-title":"Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional autoantibodies","volume":"5","author":"Johnson","year":"1990","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib64","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0168-8278(98)80205-5","article-title":"Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?","volume":"28","author":"Kaymakoglu","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2008.08.043","article-title":"Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis","volume":"7","author":"Mehendiratta","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib66","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cld.2018.06.005","article-title":"Autoimmune hepatitis, sclerosing cholangitis, and autoimmune sclerosing cholangitis overlap syndrome","volume":"22","author":"Kerkar","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2023.06.002_bib67","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/liv.12022","article-title":"Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study","volume":"33","author":"Efe","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2023.06.002_bib69","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib70","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00051-X","article-title":"Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis","volume":"3","author":"Fabien","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cld.2023.06.002_bib72","first-page":"1688","article-title":"HCV-RNA in type 2 autoimmune hepatitis","volume":"86","author":"Miyakawa","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib73","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent","volume":"54","author":"Crivelli","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2023.06.002_bib74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: c-comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.002_bib75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jceh.2022.07.002","article-title":"Post-Transplant Immunosuppression in Autoimmune Liver Disease","volume":"13","author":"Kelly","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib76","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.06.002_bib77","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cgh.2016.12.040","article-title":"Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis","volume":"16","author":"Peiseler","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and management of autoimmune hepatitis: current status and future directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut Liv"},{"key":"10.1016\/j.cld.2023.06.002_bib79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib80","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated type 1 autoimmune hepatitis","volume":"29","author":"Czaja","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2023.06.002_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.002_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040641","article-title":"Natural history, clinical features, and treatment of autoimmune hepatitis","volume":"4","author":"Czaja","year":"1984","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2023.06.002_bib83","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with an acute presentation","volume":"21","author":"Nikias","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.002_bib84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hch072","article-title":"Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u201cacute\u201d type","volume":"97","author":"Ferrari","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.cld.2023.06.002_bib85","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2023.06.002_bib86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.002_bib87","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review","volume":"52","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:00:47Z","timestamp":1761069647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1089326123000764"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}